ENDRA Life Sciences (NDRA) Shares Outstanding (2016 - 2021)
ENDRA Life Sciences (NDRA) has disclosed Shares Outstanding for 6 consecutive years, with $42.2 million as the latest value for Q3 2021.
- Quarterly Shares Outstanding rose 68.56% to $42.2 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $42.2 million through Sep 2021, up 68.56% year-over-year, with the annual reading at $1.7 million for FY2020, 484938.46% up from the prior year.
- Shares Outstanding for Q3 2021 was $42.2 million at ENDRA Life Sciences, up from $141397.0 in the prior quarter.
- The five-year high for Shares Outstanding was $42.2 million in Q3 2021, with the low at $196.0 in Q4 2020.
- Average Shares Outstanding over 5 years is $9.2 million, with a median of $3.9 million recorded in 2017.
- The sharpest move saw Shares Outstanding tumbled 100.0% in 2019, then skyrocketed 484938.46% in 2020.
- Over 5 years, Shares Outstanding stood at $3.9 million in 2017, then soared by 89.21% to $7.4 million in 2018, then crashed by 100.0% to $351.0 in 2019, then surged by 484938.46% to $1.7 million in 2020, then soared by 2376.72% to $42.2 million in 2021.
- According to Business Quant data, Shares Outstanding over the past three periods came in at $42.2 million, $41.9 million, and $41.6 million for Q3 2021, Q2 2021, and Q1 2021 respectively.